Natural compounds | Type of cancer | Preclinical Model In vitro/cancer cell lines | Molecular targets | Effects | Refs. |
---|---|---|---|---|---|
Caffeic acid phenethyl ester (CAPE) + U0126
| Pancreatic ductal adenocarcinoma | PANC-1 MIAPaCa-2 | ↓ NF-κB ↓ MAPK | ↓ Cell growth, ↑ Apoptosis (PANC-1 caspase-independent mode and MIAPaCa-2 caspase-dependent) | [51] |
Apigenin
| Choriocarcinoma | JEG3 JAR | ↓ ERK1/2 ↓ PI3K/AKT | ↓ Migratory capacity ↓ Cell viability, ↑apoptosis | [53] |
Coumestrol
| Prostate cancer | LNCaP PC3 | ↓ Phosphorylation of AKT proteins ↑ Phosphorylation f P90RSK, JNK, ERK1/2, p53 | ↓Cell proliferation ↓migration ↑apoptosis | [54] |
Quercetin | Choriocarcinoma | JEG3 JAR | ↑ Phosphorylation of p38, JNK, ERK1/2, and P90RSK proteins ↓ Phosphorylation of P70S6K, AKT, S6 | ↓ Proliferation ↓ Invasion ↓ Cell-cycle progression | [55] |
Kaempferol
| Endometrial Malignant transformation | EBM-2 HUVECs | ↓ VEGFR2 ↓ HIF-1α proteins ↓ Phosphorylation of and p38, ↓ ERK, ↓ Akt | ↓ Angiogenesis | [56] |
Genistein
| Melanoma | B16F10 | ↓ ERK, ↓ p38, ↓ JNK, ↓ Phosphorylation of tensin-2, ↓ FAK, ↓ paxillin, ↓ vinculin | ↓ Cells growth ↓ Cells migration | [57] |
Genistein and Novasoy
| Endometrial cancer | RL-95–2 ECC-1 cells | ↑ Phosphorylation of S6 only in RL-95–2 cells ↑ Phosphorylation of the p42/44 in both cell line | ↓ Cellular proliferation ↓ Cell-cycle arrest in G2 phase ↑ Apoptosis | [58] |
Resveratrol
| T-cell acute lymphoblastic leukemia | Jurkat (glucocorticoid resistant) and T-ALL cell lines, Molt-4 (glucocorticoid resistant) | ↑ p38-MAPK ↓ Akt/p70S6K/mTOR/4E-BP1 | ↑ Autophagy ↑ Apoptosis | |
Escine | Osteosarcoma | MNNG, MG-63, Saos-2, U-2OS | ↑ p38 | ↑ Autophagy ↑ Apoptosis | [61] |
Triterpenoids (21α-methylmelianodiol) | Lung cancer | A549 | ↓ ERK, ↓p-JNK, ↓p-ERK, ↓p38, ↓JNK, no effect on p-p38 | Targeting drug resistance via P-glycoprotein (P-gp)/MDR1-association | [62] |
Toosendanin | Lung cancer | H1975 and A549 cells | ↓ Snail, ↓TGFβ1, ↓ Phosphorylation of ERK | Prevents TGFβ1-induced EMT and invasion, migration, and adhesion | [63] |
Luteolin | Cervical cancer | Hela cells | ↑ Fas, ↑ phospho-JNK, ↑ p53, ↑ phospho-p38, ↑ Bax, ↓ PARP, ↓ mTOR, ↓ Bcl-2 | ↓ Cellular proliferation ↑ Apoptosis | [64] |
Baicalein
| Hepatocellular carcinoma | HepG2cell xenograft in nude mice | ↓ MEK1 ↓ Bad ↓ ERK1/2 | ↑ Intrinsic apoptosis | [65] |
Fisetin | Laryngeal cancer | TU212 cell | ↓ RAS ↓ RAF ↓ ERK1/2 | ↓ Cell migration ↓ Proliferation | [66] |
Naringenin | Prostate cancer | LNCaP and PC3 cells | ↓ p38 ERK1/2, ↓ S6, ↓ P70S6K, ↓ JNK | ↑ Apoptosis, ↑ ROS ↓ Proliferation ↓ Migration | [67] |
Silibinin | Hepatocellular carcinoma | Bel-7404 xenografts in nude mice Bel-7404 | Combined treatment with the sorafenib ↓ Phosphorylation of ERK, STAT3, AKT, MAPK p38 | ↓ Proliferation ↑ Apoptosis | |
Taxifolin | Skin cancer | skin carcinogenesis mouse model, JB6 Pþ mouse skin epidermal cells | ↓ Phosphorylation of p38, EGFR, ERKs, JNKs | ↓ Tumor incidence, ↓ Multiplicity in a solar UV (SUV)-induced skin carcinogenesis | [70] |
Delphinidin | Osteosarcoma | HOS, U2OS, MG-63 cells | ↓ Phosphorylated forms of p38 ↓ ERK | ↓ Cell migration ↓ EMT ↓ Cellular proliferation ↑ Apoptosis | [71] |
Parthenolide
| Non-small cell lung cancer | GLC-82 cells | ↓ c-Myc, ↓ B-Raf, ↓ Phosphorylation of Erk, MEK, | ↓ Invasion ↓ Proliferation ↑ Apoptosis | |
Oridonin
| Esophageal cancer | KYSE-150 c xenograft KYSE-150 cancer nude mice | ↓ Ras/Raf/MEK/ERK ↓ EGFR-mediated PI3K/AKT | ↓ Tumor angiogenesis ↓ Angiogenesis-marker CD31 ↑ Apoptosis | [74] |
Curcumin | Lung and pancreatic adenocarcinoma | p34, H1299, PC-14, Panc1 | ↓ Erk1/2 ↓ COX-2, ↓ EGFR | ↓ Survival of cancer cell ↑ Apoptosis | [75] |
Licochalcone A | Human gastric cancer | BGC-823 | ↑ JNK, ↑ ERK, ↑ p38 MAPK | ↑ Oxidative stress ↑ Apoptosis | [76] |
Pterostilbene
| Breast cancer | MCF-7 MDA-MB-231 | ↓ Akt, ↓ ERK1/2 | ↑ Apoptosis ↓ Proliferation | [77] |
Arctigenin | Gallbladder cancer | GBC-SD, NOZ GBC-SD | ↓ EGFR, ↓ p-b-Raf, ↓ p–c-Rafp-MEK, ↓ ERK, ↓ MEK, ↓ p-AKT, ↓AKT | ↑ Cancer senescence | [78] |
α-mangostin | Cervical cancer | SiHa and HeLa cells and xenograft model | ↑ p-ASK1, p-p38 p-MKK3/6 | ↑ Apoptosis | [79] |
Vitisin A | Pro-tumorigenic inflammation | RAW 264.7 cells | ↓ p38, ↓ERK, ↓ NF-κB | ↓ Proliferation | [80] |
Azaspirene
| Renal carcinoma | Renal carcinoma xenograft model HUVEC | ↓ Raf‐1 | ↓ Angiogenesis | [81] |
Rocaglamide | Leukemia | Jurkat leukemic cells | ↓ Raf-MEK-ERK | Targeting prohibitin 1 and 2 | [82] |
L-783277 | Human pancreatic cancer | PSN1 | ↓ Phosphorylation of Ras-dependent MAP kinase | ↓ Proliferation | [83] |
Magnolin | Non-small cell lung carcinoma | NCI-H1975 A549 | ↓ ERKs/RSK2 | ↓NF-κB | [84] |
Tomatidine | Sarcoma | HT1080 | ↓ ERK ↓ p38 | ↓ p38, ↓ ERK ↓ Modulation of gelatinase | [85] |
Catechol
| Lung cancer | H460 KP2 | ↓ ERK2 | ↑ c-Myc degradation ↓ ERK2 | [86] |
1,2,3-Triazole Curcumin | Non-small cell lung carcinoma | A549 | ↓ NF-κB/STAT3 ↑ mitogen-activated protein kinases | ↓ Cell proliferation | [87] |